-
CDC advisory panel backs use of GSK and Pfizer RSV vaccines in adults 60 and older
The CDC panel’s recommendation moves the U.S. closer to making the respiratory syncytial virus shots from Pfizer and GSK available to seniors.
-
More ticks are expected in the DC area this summer, experts warn
Experts are warning that there may be an uptick in ticks nationwide this summer, thanks to a warm winter. Here are some simple ways to protect yourself and your kids.
-
Tick uptick: How to protect your family this tick season
Because of the mild winter the U.S. saw, there’s been an earlier explosion in the number of ticks that were born. News4’s Erica Gonzalez and Patricia Fantis report.
-
Kesha ‘almost died' after egg freezing complication due to autoimmune disorder
The 36-year-old is known for her party anthems, but she got serious about her health journey in a new interview.
-
More than 1 million people are dropped from Medicaid as states start a post-pandemic purge of rolls
About 1.5 million people have lost Medicaid coverage in more than two dozen states as a post-coronavirus pandemic purge of the rolls gets underway. Data analyzed by The Associated Press show some states have dropped coverage for more than half the people whose eligibility cases were decided in April or May. States were prohibited from removing people from Medicaid during...
-
Do you really need 10K steps a day? Here are tips to get walking more
A new study suggests your risk of premature death decreases as your daily step count increases. News4 Consumer Reporter Susan Hogan shares the best ways to track your steps.
-
This 1-minute practice can help you ‘break up with your phone,' says author who wrote the book on it
In her book “How to Break Up With Your Phone,” Catherine Price goes into actionable practices that can help you curb your phone usage.
-
We asked beauty influencers and everyday people how much they spend on skin care: ‘I probably have more serums than shoes'
We asked influencers and people on the street about their skin care routines and how much they spend on beauty products. Here’s how they compare.
-
BMI is a flawed way to measure obesity, experts say. What else works?
Body mass index isn’t the only way to determine if a person has obesity. Here’s how other assessments stack up.
-
Mom, 37, with stage 3 breast cancer says trying on her swimsuit saved her life
After her “bikini saved her life,” Julie Devaney Hogan started Season for Squeezin’, a campaign to encourage breast cancer awareness in younger women.
-
What does it take to be wealthy? Well-being is a more important measure than money or assets, survey finds
A new Charles Schwab survey finds well-being, not money, has become the leading measure of wealth for most adults today.
-
A Missouri man died after eating raw oysters from seafood stand, health officials say
A 54-year-old Missouri man died of vibriosis after he ate raw oysters he purchased from a seafood stand, authorities said.
-
Jenna Bush Hager reflects on not owning a scale and how it impacts daughter Mila, 10
Jenna Bush Hager talked about why she doesn’t have a scale at home and how that affects her oldest daughter, Mila.
-
Doctors told me to take nasal spray, eye drops for symptoms. I had an egg-size brain tumor
Christine Spadafor had to keep pushing to get the true diagnosis after being dismissed by doctors and endured 70 medical visits during the ordeal.
-
Summer skin care myths and tips, according to dermatologist Dr. Pimple Popper
Summertime presents unique risks to your skin. Dr. Sandra Lee, aka “Dr. Pimple Popper,” breaks down facts and myths about summer skin care.
-
Alzheimer's drug gets FDA panel's backing, setting the stage for broader use
U.S. health advisers are backing the full approval of an Alzheimer’s drug that received preliminary approval last year. A panel of advisers to the Food and Drug Administration on Friday voted in favor of the infused medication from drugmakers Eisai and Biogen. The FDA granted accelerated approval in January based on early results suggesting the drug could modestly slow Alzheimer’s....
-
Chemotherapy shortage ends treatment for high school football coach with stage 4 cancer
After Jeff Bolle was diagnosed with stage 4 bile duct cancer, he had surgery to remove the tumor and then chemotherapy — until the treatment he was on ran out.
-
Gonorrhea alert!: Eye-catching billboard warns of drug-resistant STD strain
A billboard in Baltimore has a lot of people talking.
-
FDA advisors endorse Alzheimer's treatment Leqembi, paving way for full approval this summer
Medicare has promised to broadly cover Leqembi, which costs $26,500 per year, if the FDA grants full approval of the treatment.
-
FDA advisors recommend AstraZeneca, Sanofi antibody to protect babies from RSV
If the Food and Drug Administration approves nirsevimab, it will be the first medical intervention available in the U.S. that can protect infants from RSV.